4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine

C25H35N5O — CID 143500409

IUPAC4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine
SMILESCCCC(CCC1CC1)Cc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1
InChIInChI=1S/C25H35N5O/c1-2-3-19(7-6-18-4-5-18)14-21-16-26-29-24(21)25-27-22-9-8-20(15-23(22)28-25)17-30-10-12-31-13-11-30/h8-9,15-16,18-19H,2-7,10-14,17H2,1H3,(H,26,29)(H,27,28)
InChIKeyFRBORUKDVJPNKK-UHFFFAOYSA-N
MW421.59 g/mol
LogP4.93
Rot. Bonds10

About 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine

4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine (PubChem CID 143500409) has the molecular formula C25H35N5O and a molecular weight of 421.59 g/mol. Its IUPAC name is 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine.

Molecular Properties

Compound Name4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine
PubChem CID143500409
Molecular FormulaC25H35N5O
Molecular Weight421.59 g/mol
Exact Mass421.28
IUPAC Name4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine
SMILESCCCC(CCC1CC1)Cc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1
InChIInChI=1S/C25H35N5O/c1-2-3-19(7-6-18-4-5-18)14-21-16-26-29-24(21)25-27-22-9-8-20(15-23(22)28-25)17-30-10-12-31-13-11-30/h8-9,15-16,18-19H,2-7,10-14,17H2,1H3,(H,26,29)(H,27,28)
InChIKeyFRBORUKDVJPNKK-UHFFFAOYSA-N
XLogP4.93
TPSA69.83 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds10
Heavy Atoms31
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500421.59
LogP ≤ 54.93
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

butanoic acid;1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea
CID 135869575
1-benzyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide
CID 136980396
1-(2,6-difluorophenyl)-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;(2R)-2-hydroxypropanoic acid
CID 135475779
(1Z,3E,5E)-4-fluoro-2-[(E)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethenyl]hepta-1,3,5-trien-1-amine
CID 154654544
(4-fluorophenyl)-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]carbamic acid
CID 137061627
1-N'-tert-butyl-2-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-N-(1,3,4-thiadiazol-2-yl)ethene-1,1,2-triamine
CID 141451266
4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-3H-pyridine-3-carboxamide
CID 137043145
2-(3-chloro-4-methoxyphenyl)-5-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidin-4-amine
CID 170547538
3-(2-cyclopropylethyl)-N-[5-[5-(morpholin-4-ylmethyl)-6,7-dihydro-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]hexanamide
CID 136640514
2-(4-fluorophenyl)-5-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidin-4-amine
CID 170547477
2-(3-cyclopropylphenyl)-5-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidin-4-amine
CID 170547509
N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1H-pyrrolo[1,2-a]imidazole-2-carboxamide
CID 136660705

Frequently Asked Questions

What is the IUPAC name of 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine?
The IUPAC name of 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine (CID 143500409) is 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine.
What is the SMILES notation for 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine?
The canonical SMILES for 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine is CCCC(CCC1CC1)Cc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.
What is the InChIKey of 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine?
The InChIKey is FRBORUKDVJPNKK-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H35N5O/c1-2-3-19(7-6-18-4-5-18)14-21-16-26-29-24(21)25-27-22-9-8-20(15-23(22)28-25)17-30-10-12-31-13-11-30/h8-9,15-16,18-19H,2-7,10-14,17H2,1H3,(H,26,29)(H,27,28).
What are the key properties of 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine?
4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine has a molecular weight of 421.59 g/mol, XLogP of 4.93, 10 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[2-[4-[2-(2-cyclopropylethyl)pentyl]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]methyl]morpholine is sourced from PubChem (CID 143500409), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).